Continuous infusion of cefoxitin
Phase 3Small molecule
Continuous infusion of cefoxitin is one of 7 small molecule programs targeting Surgical Site Infection. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
6
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
11 competitors in Surgical Site Infection
#DrugCompanyPhaseTrials
1Keflex
Eli LillyApproved
Vancocin
HHikma Pharmaceuticals LLC
Approved
Betadine
BBecton, Dickinson and Company
Approved
Continuous infusion of cefoxitin
PPoitiers University Hospital
Phase 3
Ancef
BBaxter Healthcare Corporation
Preclinical
Garamycin
SSchering-Plough
Preclinical
Standard Antibiotic Prophylaxis
WWestern Galilee Hospital-Nahariya
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- PPoitiers University Hospital